BioLight Life Sciences Ltd (BOLT)

Currency in ILS
283.5
+12.2(+4.50%)
Closed·
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
271.6305.9
52 wk Range
209.2465.9
Key Statistics
Bid/Ask
282.00 / 303.00
Prev. Close
271.3
Open
280
Day's Range
271.6-305.9
52 wk Range
209.2-465.9
Volume
21.13K
Average Volume (3m)
12.12K
1-Year Change
-30.1896%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

BioLight Life Sciences Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Earnings

Latest Release
Aug 25, 2026
EPS / Forecast
-0.34 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BOLT Income Statement

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
−2.1x−2.6x−0.3x
PEG Ratio
−0.040.160.00
Price/Book
0.9x2.5x2.6x
Price / LTM Sales
-2.4x2.9x
Upside (Analyst Target)
-150.0%66.7%
Fair Value Upside
Unlock0.0%9.6%Unlock

BioLight Life Sciences Ltd. engages in the investment, development, management, and commercialization of products in the fields of advanced medical devices, pharmaceuticals, diagnostics, and digital medicine in Israel. The company offers TeaRx, a diagnostic platform intended for point-of-care testing of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid; TeaRx Dry Eye Syndrome; and Ocuvia, a front-to-back ocular treatment that includes ocudrip and ocugrid. It also provides Eye-D technology which treats glaucoma by the insertion of a sub-conjunctival implant; and Ocular D, a product for treating dryness in the eye with integrated vitamin D. In addition, the company engages in the development of drugs for treating eye diseases using a technological platform that enhances the transmission of active substances based on nanostructures. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Ramat Gan, Israel.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
742.46K8.18%2.01M
Other Institutional Investors
1.62M17.88%4.40M
Public Companies & Retail Investors
6.71M73.94%18.21M
Total
9.08M100.00%24.63M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rock-One International Holdings Ltd9.53%865,6472,349
Ayalon Investment House Ltd.5.66%514,2311,395

People Also Watch

179.08
CRDO
+5.53%
145.13
SKHY
+6.33%
1,925.0
ELAL
+4.34%
21,260
ENLT
-4.45%
6.159
ONDS
+1.97%

FAQ

What Is the BioLight (BOLT) Stock Price Today?

The BioLight stock price today is 283.5 ILS.

What Stock Exchange Does BioLight Trade On?

BioLight is listed and trades on the Tel Aviv Stock Exchange.

What Is the Stock Symbol for BioLight?

The stock symbol for BioLight is "BOLT."

What Is the BioLight Market Cap?

As of today, BioLight market cap is 27.77M ILS.

What Is BioLight's Earnings Per Share (TTM)?

The BioLight EPS (TTM) is -1.45.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has BioLight Stock Split?

BioLight has split 4 times.

How Many Employees Does BioLight Have?

BioLight has 4 employees.

What is the current trading status of BioLight (BOLT)?

As of Oct 19, 2026, BioLight (BOLT) is trading at a price of 283.5 ILS, with a previous close of 271.3 ILS. The stock has fluctuated within a day range of 271.6 ILS to 305.9 ILS, while its 52-week range spans from 209.2 ILS to 465.9 ILS.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.